| Product Code: ETC9680351 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand COVID-19 Therapeutics Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand COVID-19 Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand COVID-19 Therapeutics Market - Industry Life Cycle |
3.4 Thailand COVID-19 Therapeutics Market - Porter's Five Forces |
3.5 Thailand COVID-19 Therapeutics Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
4 Thailand COVID-19 Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of COVID-19 cases in Thailand |
4.2.2 Government initiatives to improve healthcare infrastructure and access to therapeutics |
4.2.3 Growing investments in research and development for COVID-19 therapeutics |
4.3 Market Restraints |
4.3.1 Stringent regulatory approvals for new therapeutics |
4.3.2 Limited availability of skilled healthcare professionals for therapeutics administration |
4.3.3 Economic challenges impacting healthcare spending and affordability of therapeutics |
5 Thailand COVID-19 Therapeutics Market Trends |
6 Thailand COVID-19 Therapeutics Market, By Types |
6.1 Thailand COVID-19 Therapeutics Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Thailand COVID-19 Therapeutics Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Thailand COVID-19 Therapeutics Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.1.4 Thailand COVID-19 Therapeutics Market Revenues & Volume, By Anti-viral, 2021- 2031F |
6.1.5 Thailand COVID-19 Therapeutics Market Revenues & Volume, By Monoclonal Antibodies, 2021- 2031F |
6.1.6 Thailand COVID-19 Therapeutics Market Revenues & Volume, By Kinase Inhibitors, 2021- 2031F |
6.1.7 Thailand COVID-19 Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
7 Thailand COVID-19 Therapeutics Market Import-Export Trade Statistics |
7.1 Thailand COVID-19 Therapeutics Market Export to Major Countries |
7.2 Thailand COVID-19 Therapeutics Market Imports from Major Countries |
8 Thailand COVID-19 Therapeutics Market Key Performance Indicators |
8.1 Number of clinical trials conducted for COVID-19 therapeutics in Thailand |
8.2 Adoption rate of new COVID-19 therapeutics in the market |
8.3 Patient outcomes and recovery rates post-administration of COVID-19 therapeutics |
8.4 Government funding allocated specifically for COVID-19 therapeutics research and development |
8.5 Rate of hospitalizations due to COVID-19 compared to the usage of therapeutics |
9 Thailand COVID-19 Therapeutics Market - Opportunity Assessment |
9.1 Thailand COVID-19 Therapeutics Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
10 Thailand COVID-19 Therapeutics Market - Competitive Landscape |
10.1 Thailand COVID-19 Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Thailand COVID-19 Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here